Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p-Reference-Cited by-同舟云学术

Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p

Published:2022-05-02 Issue:5 Volume:13 Page:13201-13212
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Liao Guansheng¹,Huang Zhuoya²,Gan Tianyu¹,Wu Cong¹,Wang Xiaolong¹,Li Dexiang¹

Affiliation:

1. Department of Thyroid Surgery, Huizhou Central People’s Hospital, Huizhou, Guangdong, China

2. Department of Pathology, Huizhou Central People’s Hospital, Huizhou, Guangdong, China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2076498

Reference32 articles.

1. Thyroid carcinoma: molecular pathways and therapeutic targets

2. Early evolutionary divergence between papillary and anaplastic thyroid cancers

3. Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma

4. Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

5. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Thyroid Cancer: Emerging Opportunities from Non-Coding RNAs and Mitochondrial Space;International Journal of Molecular Sciences;2024-06-18

2. Progress in long non-coding RNAs as prognostic factors of papillary thyroid carcinoma;Pathology - Research and Practice;2024-04

3. Identification of ID1 and miR-150 interaction and effects on proliferation and apoptosis in ovine granulosa cells;Theriogenology;2023-12

4. BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma;BMC Cancer;2023-10-18